Not Medicare Enrolled

Dr. Kimberly Sanchez Dal Porto, MD

Pediatric Adolescent Medicine · Jacksonville, FL
2121 PARK ST, Jacksonville, FL 32204
9043876200
Registered in NPPES since 2005
NPI: 1366435570 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sanchez Dal Porto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanchez Dal Porto? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sanchez Dal Porto

Dr. Kimberly Sanchez Dal Porto is a pediatric adolescent medicine specialist in Jacksonville, FL, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Sanchez Dal Porto received a total of $1,007 from 23 pharmaceutical and/or device companies across 58 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sanchez Dal Porto is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration $1,007 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,007
Total received (2018-2024)
Avg $144/year across 7 years
Top 15% in FL for pediatric adolescent medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
58
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$292
2023
$175
2022
$112
2021
$136
2020
$34
2019
$111
2018
$147

Payments by company (2024)

Corium, LLC
$80
Merck Sharp & Dohme LLC
$58
Cranial Technologies, Inc
$39
IRONSHORE PHARMACEUTICALS INC.
$32
SOBI, INC
$29
AstraZeneca Pharmaceuticals LP
$21
ACADIA Pharmaceuticals Inc
$17
kaleo, Inc.
$17
Top 3 companies account for 60.5% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$150
Corium, LLC
$122
Takeda Pharmaceuticals U.S.A., Inc.
$109
PFIZER INC.
$89
kaleo, Inc.
$48
Tris Pharma Inc
$45
Sanofi Pasteur Inc.
$42
Cranial Technologies, Inc
$39
Shire North American Group Inc
$39
ARBOR PHARMACEUTICALS, INC.
$36
SANOFI PASTEUR INC.
$35
IRONSHORE PHARMACEUTICALS INC.
$32
Sobi, Inc
$32
SOBI, INC
$29
Ultragenyx Pharmaceutical Inc.
$25
Merck Sharp & Dohme Corporation
$23
AstraZeneca Pharmaceuticals LP
$21
Seqirus USA Inc
$19
Verrica Pharmaceuticals Inc.
$18
ACADIA Pharmaceuticals Inc
$17
Mylan Pharmaceuticals Inc.
$13
Kaleo, Inc.
$12
Ironshore Pharmaceuticals Inc.
$11
Top 3 companies account for 37.9% of all-time payments
Associated products mentioned in payments ›
AUVI-Q · AZSTARYS · Azstarys · BEYFORTUS · CRYSVITA · DAYBUE · Doc Band · Dyanavel XR · EUCRISA · Evekeo · FLUCELVAX QUADRIVALENT · FLUMIST QUADRIVALENT · GARDASIL · GARDASIL 9 · GARDASIL9 · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · MENQUADFI · MYDAYIS · NO PRODUCT DISCUSSED · Otovel · PREVNAR - 13 · PREVNAR 13 · PROQUAD · Quillivant XR · ROTATEQ · SYNAGIS · VAXELIS · VYVANSE · Vusion · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric adolescent medicine specialist in Jacksonville?
Compare pediatric adolescent medicines in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse pediatric adolescent medicines nearby

Geographic Context

Pediatric adolescent medicines in nearby ZIP areas
20
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sanchez Dal Porto is a pediatric adolescent medicine specialist, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Sanchez Dal Porto receive payments from pharmaceutical companies?
Yes. Dr. Sanchez Dal Porto received a total of $1,007 from 23 companies across 58 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Sanchez Dal Porto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Adolescent Medicines in Jacksonville
Browse pediatric adolescent medicines in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Adolescent Medicines in FL
Pediatric adolescent medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Adolescent Medicines in FL
Which FL pediatric adolescent medicines receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →